Jim Mazzola | Senior Vice President, Communication and Investor Relations |
Athena Countouriotis | President, Chief Executive Officer |
Yi Larson | Executive Vice President, Chief Financial Officer |
Michael Schmidt | Guggenheim |
Corinne Jenkins | Goldman Sachs |
David Nierengarten | Wedbush Securities |
Matt Biegler | Oppenheimer |
Nick Abbott | Wells Fargo |
Zegbeh Jallah | ROTH Capital Partners |
Silvan Türkcan | JMP Securities |
Arlinda Lee | Canaccord |
Ladies and gentlemen, thank you for standing by and welcome to the Turning Point Therapeutics' fourth quarter 2020 conference call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions]. I would now like to hand the conference to your speaker today, Mr.